Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma

High recurrence rates and poor survival of patients with esophageal squamous cell carcinoma (ESCC) after treatment make ongoing research on chemoprevention drugs for ESCC particularly important. In this study, we screened a large number of FDA-approved drugs and found levodopa, a drug used to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhenzhen, Li, Xin, He, Xinyu, Jia, Xuechao, Zhang, Xiaofan, Lu, Bingbing, Zhao, Jimin, Lu, Jing, Chen, Lexia, Dong, Ziming, Liu, Kangdong, Dong, Zigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546765/
https://www.ncbi.nlm.nih.gov/pubmed/33101026
http://dx.doi.org/10.3389/fphar.2020.568459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546765/
https://www.ncbi.nlm.nih.gov/pubmed/33101026
http://dx.doi.org/10.3389/fphar.2020.568459

Ejemplares similares